FORT LAUDERDALE, Fla., Sept. 14 /PRNewswire/ -- MAKO Surgical Corp., a developer of minimally invasive, surgeon-interactive, haptic robotic technology for knee surgery, announced today that Frederic H. Moll, M.D., has been named to the company’s Board of Directors, effective August 24, 2007.
Dr. Moll has over 20 years experience in the medical device industry. Most recently, he co-founded Hansen Medical Inc. in September 2002 and currently serves as the company’s Chief Executive Officer and Director.
“Fred Moll’s knowledge and reputation are well known in the medical device industry. His pioneering and experience in surgical robotics and their commercialization will provide significant value to MAKO,” said MAKO Surgical Corp. President and CEO Maurice R. Ferre, M.D.
Prior to co-founding Hansen Medical Inc., Dr. Moll co-founded Intuitive Surgical Inc., a medical device company, in November 1995 and served as its first Chief Executive Officer and later, its Vice President and Medical Director, until September 2003. In 1989, Dr. Moll co-founded Origin Medsystems, Inc., a medical device company, which later became an operating company within Guidant Corporation, following its acquisition by Eli Lilly in 1992. Dr. Moll served as Medical Director of Guidant’s Surgical Device Division until November 1995.
About MAKO Surgical Corp.
MAKO Surgical Corp. is a privately held, emerging orthopedic medical device company developing innovative restorative solutions for keyhole orthopedic surgery. Founded in November 2004, the company has developed and released the MAKO Haptic Guidance System(TM) (HGS(TM)). This FDA-cleared, surgeon-interactive robotic system allows surgeons to provide an innovative tissue-sparing bone resurfacing therapy called MAKOplasty(TM) to a large, yet significantly underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKOplasty(TM) empowers orthopedic surgeons to improve patient outcomes, shorten recovery time and enhance post- operative lifestyle. More than 75 MAKOplasty(TM) unicondylar knee resurfacing procedures have been performed to date. MAKO’s proprietary technology is protected by more than 240 patents and patent applications in the areas of robotics, haptics, robotic surgery, image guided surgery and implants. For more information, please visit www.makosurgical.com.
MAKO Surgical Corp.
CONTACT: Cynthia Kalb of MAKO Surgical Corp., +1-954-927-2044, x426,ckalb@makosurgical.com
Web site: http://www.makosurgical.com/
